Mark Nelson, M.A., M.B.B.S., M.R.C.P.
As those titles would suggest, Dr. Nelson is heavily involved in clinical studies at Chelsea and Westminster; his HIV-related research has run the gamut, though his latest work tends to focus on antiretroviral therapies, treatment of HIV/hepatitis B coinfection and AIDS-related lymphoma. Dr. Nelson has authored or co-authored more than 50 published articles over the past two years.
In addition to his clinical duties, Dr. Nelson teaches undergraduates and graduates at Chelsea and Westminster Hospital, and has lectured extensively throughout the world at conferences and as an invited speaker.
Dr. Nelson received his bachelor's degree at Abingdon School in Oxford in 1980; he received his M.B.B.S. (Bachelor of Medicine/Bachelor of Surgery) from Jesus College in Cambridge three years later, and his Master of Arts degree in 1986 from Westminster Hospital Medical School in London. He is a fellow of the Royal College of Physicians and a recipient of the Chadwick Prize in Surgery.
Dr. Nelson has been a consultant for Merck Sharp & Dohme, GlaxoSmithKline, Bristol-Myers Squibb, Roche Laboratories, Tibotec, Johnson & Johnson, Idenix Pharmaceuticals, Gilead Sciences, Abbott Laboratories, Schering-Plough Corporation and Boehringer Ingelheim. In addition, he has served on speakers bureaus for Merck Sharp & Dohme, GlaxoSmithKline, Bristol-Myers Squibb, Roche, Tibotec, Johnson & Johnson, Idenix, Gilead, Abbott, Schering-Plough and Boehringer Ingelheim. He has also received research support from Merck Sharp & Dohme, Roche, Tibotec, Gilead and Abbott.